Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | S19 - MS Biomarkers and Symptom Management

Tuesday 04/05/22
01:00 PM - 03:00 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Multiple Sclerosis
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:00 PM PDT Speaker Walk-in Slides
Erin Jackson
01:00 PM - 01:12 PM PDT Abstract 001 - Applicability of sNFL in Multiple Sclerosis as Additional Measure to Monitor Treatments in Clinical Practice and Implications in NEDA-3 Evaluation
Simona Malucchi
01:12 PM - 01:24 PM PDT Abstract 002 - Early Levels of Neurofilament Light Chain and Glial Fibrillary Acidic Protein Improve Prediction of MS Outcomes
Gauruv Bose, MD
01:24 PM - 01:36 PM PDT Abstract 003 - Kappa Free Light Chains Intrathecal Synthesis Biomarkers are Efficient Tools for the Diagnosis of Multiple Sclerosis: a Large Multicenter Cohort Study
Christine Lebrun Frenay, MD, FAAN
01:36 PM - 01:48 PM PDT Abstract 004 - Utilizing P100 Wave Latency to Enhance The Accuracy of Diagnosing Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Mays Amir Garah, MBBS
01:48 PM - 02:00 PM PDT Abstract 005 - Increased Serum Neurofilament Light and Thin Ganglion Cell–Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis
Ting-Yi Lin, MD
02:00 PM - 02:12 PM PDT Abstract 006 - Lower Cerebral Arterial Blood Flow is Associated with Greater Serum Neurofilament Light Chain Levels in Multiple Sclerosis Patients
Dejan Jakimovski, MD, PhD
02:12 PM - 02:24 PM PDT Abstract 007 - Monoaminergic Networks Abnormalities Associated with Fatigue and Depression in Multiple Sclerosis
Paolo Preziosa
02:24 PM - 02:36 PM PDT Abstract 008 - Repetitive transcranial magnetic stimulation with the H-coil combined with intensive rehabilitation to improve gait in people with Multiple Sclerosis: a randomized controlled trial
Letizia M. Leocani, MD
02:36 PM - 02:48 PM PDT Abstract 009 - Long-term efficacy of cognitive-behavioral approaches (CBT) in the management of fatigue in patients with relapsing remitting multiple sclerosis (RRMS): a randomized, parallel-group, multicenter, open-label, controlled trial versus standard care
Olivier Heinzlef, MD
02:48 PM - 03:00 PM PDT Abstract 010 - Assessing cognitive impairment in Multiple Sclerosis using Smartphone-Based training Games: Results of a feasibility study
Tim Woelfle
Faculty Disclosures
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Ludwig Kappos, MD, FAAN The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Edward J. Cupler, MD, FAAN Dr. Cupler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Rohit Bakshi, MD, FAAN Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. An immediate family member of Dr. Bakshi has received stock or an ownership interest from Biogen. The institution of Dr. Bakshi has received research support from BMS/Celgene. The institution of Dr. Bakshi has received research support from EMD Serono.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Letizia M. Leocani, MD Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Olivier Heinzlef, MD Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Edimark.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique.
Marco Rovaris No disclosure on file
Antonio Bertolotto, MD, FAAN Dr. Bertolotto has nothing to disclose.
Charles R.G. Guttmann Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Filterlex. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for 3D Communications. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Maria Assunta Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Jean Pelletier, MD, PhD Dr. Pelletier has nothing to disclose.
Simona Malucchi No disclosure on file
Areej Bushnag, MD No disclosure on file
Erin Jackson Ms. Jackson has nothing to disclose.
Yvonne Naegelin, MD Dr. Naegelin has nothing to disclose.
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
David Laplaud No disclosure on file
Pasquale Calabrese, PhD Dr. Calabrese has nothing to disclose.
Fawzi Babtain, MD Dr. Babtain has nothing to disclose.
Jean-Phillippe Camdessanche Jean-Phillippe Camdessanche has nothing to disclose.
Jens Kuhle, MD Dr. Kuhle has nothing to disclose.
Ilana B. Katz Sand, MD The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with American Academy of Neurology.
Michael G. Dwyer, III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Paola Valsasina Paola Valsasina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACCMED.
Fabiana Marnetto Fabiana Marnetto has nothing to disclose.
Niels Bergsland Prof. Bergsland has nothing to disclose.
Bonnie Glanz The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Friedemann Paul The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe PC (MTPC). The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aarhus University. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CELGENE. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACRELION. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizter. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Mariann Polgar-Turcsanyi Mariann Polgar-Turcsanyi has nothing to disclose.
Jiwon Oh, MD, FAAN Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Olivier Casez, MD Dr. Casez has nothing to disclose.
Brian Curran Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Judith Bellmann-Strobl, MD Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
Thierry Vincent Thierry Vincent has nothing to disclose.
Athina Papadopoulou, MD The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Schweiz AG. The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie AG. The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Papadopoulou has received research support from Freie Akademische Gesellschaft Basel . Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving as a Travel Support (for Congress) with Eli Lilly. Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving as a Travel support (for Congress) with TEVA.
Manal A. Badawi, MD Dr. Badawi has nothing to disclose.
Mikael Cohen Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Alexander U. Brandt, MD No disclosure on file
Klemens Ruprecht, MD Dr. Ruprecht has received research support from European Union (821283-2). Dr. Ruprecht has received research support from Merck Serono. Dr. Ruprecht has received research support from Stiftung Charite. Dr. Ruprecht has received research support from Arthur Arnstein Foundation. Dr. Ruprecht has received publishing royalties from a publication relating to health care.
Saskia Bresch, MD Dr. Bresch has nothing to disclose.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Hanna Zimmermann Hanna Zimmermann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis and Bayer. The institution of Hanna Zimmermann has received research support from Novartis.
Eric Manchon, MD Eric Manchon, MD has nothing to disclose.
Eric Thouvenot, MD, PhD Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biologix FZCo.. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HEALTHME. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Jonathan Ciron, MD Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS - Celgene. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Xavier Ayrignac Xavier Ayrignac has nothing to disclose.
Thibault Moreau Thibault Moreau has nothing to disclose.
Gauruv Bose, MD Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. The institution of Dr. Bose has received research support from Multiple Sclerosis Society of Canada.
Djamel Bensmail Djamel Bensmail has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MERZ. Djamel Bensmail has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Djamel Bensmail has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Djamel Bensmail has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for medtronic. Djamel Bensmail has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERZ. Djamel Bensmail has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan.
Gloria Dalla Costa Gloria Dalla Costa has nothing to disclose.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Laura Cacciaguerra, MD, PhD Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOMEDIA.
Antonio Carotenuto Mr. Carotenuto has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk, Novartis, Roche and Almirall. The institution of Mr. Carotenuto has received research support from ALMIRALL. The institution of Mr. Carotenuto has received research support from Carotenuto Antonio.
Barbara Seitz-Polski, 2779 Barbara Seitz-Polski, 2779 has received intellectual property interests from a discovery or technology relating to health care.
Marco Pisa, MD Dr. Pisa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Damien Biotti Damien Biotti has nothing to disclose.
Dejan Jakimovski, MD, PhD Dr. Jakimovski has nothing to disclose.
Johannes Lorscheider The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Johannes Lorscheider has received research support from Innosuisse - Swiss Innvation Ageny. The institution of Johannes Lorscheider has received research support from MSBase Foundation. The institution of Johannes Lorscheider has received research support from Novartis.
Marco Alfonso Narduc Capobianco Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Giancarlo *USE ID 014384 Comi Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rewind.
Lama Rayyis, MBBS Dr. Rayyis has nothing to disclose.
Claudia Chien The institution of Claudia Chien has received research support from Novartis. The institution of Claudia Chien has received research support from Alexion. Claudia Chien has a non-compensated relationship as a Standing Committee on Science Member with Canadian Institutes for Health Research that is relevant to AAN interests or activities.
Gulzar Karim Gulzar Karim has nothing to disclose.
Shrishti Saxena No disclosure on file
Marie Claire Gay No disclosure on file
Marinos G. Sotiropoulos, MD The institution of Dr. Sotiropoulos has received research support from Mallinckrodt. The institution of Dr. Sotiropoulos has received research support from United States Department of Defense. Dr. Sotiropoulos has received research support from World Health Organization.
Serena Martire Serena Martire has nothing to disclose.
Seyedamirhosein Motamedi, PhD Mr. Motamedi has nothing to disclose.
Hrishikesh A. Lokhande Mr. Lokhande has nothing to disclose.
Sophie Huby No disclosure on file
Fanny Hamelin Fanny Hamelin has nothing to disclose.
Kevin Bigaut Kevin Bigaut has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kevin Bigaut has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Fermisk Saleh Fermisk Saleh has nothing to disclose.
Ahmad Hassan Ahmad Hassan has nothing to disclose.
Simone Guerrieri, MD Dr. Guerrieri has nothing to disclose.
Aude Maurousset Aude Maurousset has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Aude Maurousset has received personal compensation in the range of $0-$499 for serving as a Consultant for merck. Aude Maurousset has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for roche.
Pascal Benkert Pascal Benkert has nothing to disclose.
Raffaello Bonacchi Raffaello Bonacchi has nothing to disclose.
Noellie Freitas No disclosure on file
Elisabeth Maillart Elisabeth Maillart has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Elisabeth Maillart has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Elisabeth Maillart has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Elisabeth Maillart has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Elisabeth Maillart has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Elisabeth Maillart has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Elisabeth Maillart has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Elisabeth Maillart has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Elisabeth Maillart has received research support from Biogen.
Beverly Aagard-Kienitz No disclosure on file
Mays Amir Garah, MBBS Dr. Garah has nothing to disclose.
Anu Paul, PhD Anu Paul has nothing to disclose.
Ting-Yi Lin, MD Dr. Lin has nothing to disclose.
Michael Levraut, MD Dr. Levraut has received research support from Faculté de médecine de Nice.
Jeanne Marion, Jr., Other Miss MARION has nothing to disclose.
Yannick Tholance, MD,PhD Dr. THOLANCE has nothing to disclose.
Edith Bigot-Corbel, PhD Dr. BIGOT-CORBEL has nothing to disclose.
Manon Rival, MD Mrs. Rival has nothing to disclose.
Marie Blanchere, Jr., PhD Mrs. Blanchere has nothing to disclose.
Frederic Barbot, Other Dr. Barbot has nothing to disclose.
Marc Ditzhaus Dr. Ditzhaus has nothing to disclose.
Thomasset Audrey Miss Audrey has nothing to disclose.
Auriane Rocher, Jr., MD Dr. Rocher has nothing to disclose.
Ivette Martorell Serra, Other Ms. Martorell Serra has nothing to disclose.
Sabine Chabalier, PhD Dr. Chabalier has nothing to disclose.
Hanane Agherbi, PhD Dr. AGHERBI has nothing to disclose.
Delphine Sterlin, PhD,Other Dr. Sterlin has nothing to disclose.
Silvan Pless, Other Mr. Pless has nothing to disclose.
Tim Woelfle The institution of Dr. Woelfle has received research support from Foundation Clinical Neuroimmunology and Neuroscience Basel. The institution of Dr. Woelfle has received research support from Swiss Innovation Agency (Innosuisse) – Project ID: 33535.1 IP-ICT.
Viktoriya Vitkova, Other Ms. Vitkova has nothing to disclose.
Paola Valentino, Other Dr. Valentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche S.p.a..
Isabelle Vaugier, MD Mrs. Vaugier has nothing to disclose.
Cecelia Irene Bava Dr. BAVA has nothing to disclose.
Andrea Wiencierz, PhD Ms. Wiencierz has nothing to disclose.
Tifanie Alberto Miss Alberto has nothing to disclose.
Óscar Gabriel Reyes Pupo, PhD Dr. Reyes Pupo has nothing to disclose.
Kunsang Choedun, Other Mrs. Choedun has nothing to disclose.
Jose Maria Santos, Sr., Other Mr. SANTOS has received personal compensation for serving as an employee of Healios AG.
José Boucraut, MD,PhD Dr. Boucraut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SEBIA. Dr. Boucraut has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Polyneuron Pharmaceutical SA. The institution of Dr. Boucraut has received research support from CSL Behring. The institution of Dr. Boucraut has received research support from Polyneuron Pharmaceutical SA.
Sanae Squalli, PhD Dr. Squalli has nothing to disclose.
Vincent Visneux, Other Mr. VISNEUX has nothing to disclose.
Susanna Asseyer, MD Dr. Asseyer has received personal compensation in the range of $0-$499 for serving as a speaker with Alexion. Dr. Asseyer has received personal compensation in the range of $0-$499 for serving as a speaker with Roche Pharma AG. Dr. Asseyer has received personal compensation in the range of $0-$499 for serving as a speaker with Bayer AG.
Adrien Delourme, MD Dr. Delourme has nothing to disclose.
Karen L. Marr, Other Ms. MARR has nothing to disclose.
Jean David Pekar, MD Dr. PEKAR has nothing to disclose.
Daniela Lakomy Dr. Lakomy has nothing to disclose.
Isabelle Jahn, PhD Dr. Jahn has nothing to disclose.
Ahmed Basndowah No disclosure on file
Audrey Le Gouellec No disclosure on file